Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 20, 2019 - Issue 8
Submit an article Journal homepage
13,391
Views
19
CrossRef citations to date
0
Altmetric
Editorial

Clinical considerations for oral beta-lactams as step-down therapy for Enterobacteriaceae bloodstream infections

Bryan T. MogleDepartment of Pharmacy, State University of New York Upstate University Hospital, Syracuse, NY, USAORCID Iconhttp://orcid.org/0000-0003-2993-6366View further author information
ORCID Icon,
Mario V. BeccariDepartment of Pharmacy, State University of New York Upstate University Hospital, Syracuse, NY, USAView further author information
,
Jeffrey M. SteeleDepartment of Pharmacy, State University of New York Upstate University Hospital, Syracuse, NY, USA;Department of Medicine, State University of New York Upstate Medical University, Syracuse, NY, USAView further author information
,
Tasaduq FaziliDepartment of Medicine, State University of New York Upstate Medical University, Syracuse, NY, USAView further author information
&
Wesley D. KufelDepartment of Pharmacy, State University of New York Upstate University Hospital, Syracuse, NY, USA;Department of Medicine, State University of New York Upstate Medical University, Syracuse, NY, USA;Department of Pharmacy Practice, Binghamton University School of Pharmacy and Pharmaceutical Sciences, Binghamton, NY, USACorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-7703-096XView further author information
ORCID Icon
Pages 903-907 | Received 21 Dec 2018, Accepted 11 Mar 2019, Published online: 25 Mar 2019

References

  • Sutton JD, Sayood S, Spivak ES. Top questions in uncomplicated, non-Staphylococcus aureus bacteremia. Open Forum Infect Dis. 2018;5(5):ofy087.
  • Kutob LF, Justo JA, Bookstaver PB, et al. Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections. Int J Antimicrob Agents. 2016;48:498–503.
  • Mercuro NJ, Stogsdill P, Wungwattana M. Retrospective analysis comparing oral stepdown therapy for enterobacteriaceae bloodstream infections: fluoroquinolones versus beta-lactams. Int J Antimicrob Agents. 2018;51:687–692.
  • Rieger KL, Bosso JA, MacVane SH, et al. Intravenous-only or intravenous transitioned to oral antimicrobials for enterobacteriaceae-associated bacteremic urinary tract infection. Pharmacotherapy. 2017;37:1479–1483.
  • Tandan M, Cormican M, Vellinga A. Adverse events of fluoroquinolones vs. other antimicrobials prescribed in primary care: a systematic review and meta-analysis of randomized controlled trials. Int J Antimicrob Agents. 2018;52(5):529–540.
  • Ho JM, Juurlink DN. Considerations when prescribing trimethoprim-sulfamethoxazole. Cmaj. 2011 8. 183(16):1851–1858.
  • Shea KM, Hobbs ALV, Jaso TC, et al. Effect of a health care system respiratory fluoroquinolone restriction program to alter utilization and impact rates of clostridium difficile infection. Antimicrob Agents Chemother. 2017;61(6):e00125–17.
  • MacGregor RR, Graziani AL. Oral administration of antibiotics: a rational alternative to the parenteral route. Clin Infect Dis. 1997;24(3):457–467.
  • Omnicef (cefdinir) [prescribing information]. North Chicago (IL): Abbott Laboratories; 2007.
  • Cipro (ciprofloxacin) [prescribing information]. Whippany (NJ): Bayer Healthcare Pharmaceuticals Inc; 2017.
  • Auckenthaler R. Pharmacokinetics and pharmacodynamics of oral beta-lactam antibiotics as a two-dimensional approach to their efficacy. J Antimicrob Chemother. 2002;50 Suppl:13–17.
  • Lodise TP, Lomaestro BM, Drusano GL. Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2006;26(9):1320–1332.
  • Turnidge JD. The pharmacodynamics of beta-lactams. Clin Infect Dis. 1998;27(1):10–22.
  • CLSI. Performance standards for antimicrobial disk susceptibility tests. 13th ed. Wayne (PA): Clinical and Laboratory Standards Institute; 2018. CLSI standard M02.
  • Mouton JW, Muller AE, Canton R, et al. MIC-based dose adjustment: facts and fables. J Antimicrob Chemother. 2018 Mar 1;73(3):564–568.
  • EUCAST. Antimicrobial wild type distributions of microorganisms. Vaxjo, Sweden: European Committee on Antimicrobial Susceptibility Testing; 2018. Available from https://mic.eucast.org/Eucast2/SearchController/search.jsp?action=init
  • Yahav D, Franceschini E, Koppel F, et al. Seven versus fourteen days of antibiotic therapy for uncomplicated Gram-negative bacteremia: a non-inferiority randomized controlled trial. Clin Infect Dis. 2018; Epub ahead of print.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.